Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
- Study Title
- Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
- Teva Identifier
- IXR-102-22-188
- ClinicalTrials.gov Identifier
- NCT00071539
- Study Status
- Completed
- Trial Condition(s)
- Recurrent Glioblastoma Multiforme
- Interventions
- Drug: TP-38 | Drug: TP38
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 10/01/2003 - 07/01/2006
- Phase
- Phase 2
